Skip to main content

Animations

MJFF Publications

2581 - 2590 of 6284 Results
Title
Year
  • Year
  • 2016
  • 2016
  • 2016
  • 2009
  • 2016
  • 2012
  • 2008
  • 2011
  • 2012
  • 2013
  • Summary Details
    OPEN
    Title: Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26621
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Clinical and demographic characteristics related to onset site and spread of cervical dystonia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26817
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Assessing medication role on neuropathological findings in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26536
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26665
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Role of Elongation and Secondary Pathways in S6 Amyloid Fibril Growth
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bpj.2012.03.047
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.08.087
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: Unexpected ‘molecular switch’ from a closely related mGlu4 positive allosteric modulator
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2011.09.131
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
    Journal Name: Neurochemistry International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/nmt.12.75
    Best OA location URL:
    Citation Count: 34
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.